Search Results

ORCL Oracle Corporation - Fundamental Analysis

NEUTRAL
Sign in to save Save this symbol to a watchlist or track a position.
ORCL Stock | Fundamental Analysis & Investment Insights
NASDAQ Technology Software - Infrastructure
Current Price Live
$191.09
Analyst Target
$291.61
+52.6% Upside
52W High
$345.72
52W Low
$118.86

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 17, 2026
Market cap
$549.03B
P/E
35.92
ROE
69.0%
Profit margin
25.3%
Debt/Equity
4.33
Dividend yield
1.05%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
72%
Analysis Accuracy
Oracle's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. The company exhibits robust profitability with a 69.03% ROE and 32% operating margin, supported by strong double-digit revenue and earnings growth. However, elevated valuation metrics—P/E of 35.92 and Price/Book of 18.33—suggest the stock trades at a significant premium, further compounded by bearish insider activity and weak short-term technical trends. While analyst consensus supports a 'buy' recommendation with a target price of $291.61, the current price of $191.09 sits well above the Graham Number of $35.33, indicating limited margin of safety for defensive investors.

Key Strengths

Exceptional profitability with ROE of 69.03% and operating margin of 32.00%, well above sector averages
Strong year-over-year earnings growth of 90.90% and revenue growth of 14.20%, demonstrating sustained top- and bottom-line momentum
High return metrics: ROIC not available, but ROE significantly exceeds peer average of 29.76%
Defensive dividend with a sustainable 35.71% payout ratio and consistent yield around 1.05%
Analyst consensus strongly supportive with a $291.61 target price, implying ~52% upside

Key Risks

Low Piotroski F-Score of 4/9 signals suboptimal financial health, particularly concerning liquidity and leverage
Very high debt/equity ratio of 4.33, far above sector average of 0.80, increasing financial risk
Current ratio of 0.91 and quick ratio of 0.77 indicate potential near-term liquidity pressure
Bearish insider sentiment: 10 sell transactions totaling $55.71M in the last 6 months with no buys
Technical trend rated 0/100, indicating strong short-term bearish momentum despite long-term growth
AI Fair Value Estimate
Based on comprehensive analysis
$156.94
-17.9% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
61
Strong
Value
45
Future
80
Past
70
Health
50
Dividend
60
AI Verdict
Moderately positive with caution due to valuation and health metrics
Key drivers: High profitability and growth, Elevated valuation multiples, Weak Piotroski score, Bullish analyst outlook, Bearish insider and technical signals
Confidence
75%
Value
45/100

Ref P/E, PEG, Graham Number

Positives
  • Intrinsic Value (Formula) of $156.94 provides growth-based support
  • Forward P/E of 24.03 is more reasonable than current P/E of 35.92
Watchpoints
  • Current price ($191.09) is 440% above Graham Number ($35.33)
  • P/E of 35.92 and Price/Book of 18.33 are extremely high vs. sector averages
Future
80/100

Ref Growth rates

Positives
  • YoY earnings growth of 90.90% and Q/Q EPS growth of +123.8%
  • Revenue growth of 14.20% in a mature sector indicates strong demand
Watchpoints
  • PEG Ratio not available, limiting growth-adjusted valuation insight
Past
70/100

Ref Historical trends

Positives
  • Long-term price performance strong: +233.9% over 5 years
  • History of consistent earnings beats with average surprise of 12.56% in recent quarters
Watchpoints
  • Recent 6-month return of -21.8% and 1-week drop of -3.7% show weakening momentum
Health
50/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • No Altman Z-Score distress flag (though data missing)
  • Positive ROA of 6.86% indicates asset efficiency
Watchpoints
  • Piotroski F-Score of 4/9 indicates weak financial health
  • Debt/Equity of 4.33 is dangerously high
  • Current and quick ratios below 1.0 signal liquidity risk
Dividend
60/100

Ref Yield, Payout

Positives
  • Payout ratio of 35.71% is sustainable
  • Dividend Strength score of 40/100 suggests room for improvement
Watchpoints
  • Dividend yield of 1.05% is modest compared to income-focused peers
  • 5-Year Avg Yield data unavailable, limiting trend analysis

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$191.09
Analyst Target
$291.61
Upside/Downside
+52.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ORCL and closest competitors.

Updated 2026-01-16
Company 5Y 3Y 1Y 6M 1M 1W
ORCL
Oracle Corporation
Primary
+233.9% +123.6% +21.0% -21.8% +7.4% -3.7%
ASML
ASML Holding N.V.
Peer
+160.4% +141.1% +109.7% +95.9% +2.1% -1.3%
PLTR
Palantir Technologies Inc.
Peer
+992.3% +1986.5% +194.0% +34.4% -3.1% -2.2%
MU
Micron Technology, Inc.
Peer
+334.8% +547.4% +254.7% +217.4% +60.9% +5.1%
AMD
Advanced Micro Devices, Inc.
Peer
+134.4% +121.1% +97.1% +22.0% -9.4% +0.5%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
35.92
Forward P/E
24.03
PEG Ratio
N/A
P/B Ratio
18.33
P/S Ratio
9.0
EV/Revenue
10.84
EV/EBITDA
25.18
Market Cap
$549.03B

Profitability

Profit margins and return metrics

Profit Margin 25.28%
Operating Margin 32.0%
Gross Margin 68.54%
ROE 69.03%
ROA 6.86%

Growth

Revenue and earnings growth rates

Revenue Growth +14.2%
Earnings Growth +90.9%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +94.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
4.33
High debt
Current Ratio
0.91
Weak
Quick Ratio
0.77
Poor
Cash/Share
$6.88

Quarterly Earnings History

EPS performance vs analyst estimates

2026-03-09
$N/A
2025-12-10
$2.26
+38.0% surprise
2025-09-09
$1.01
-3.7% surprise
2025-06-11
$1.7
+3.4% surprise

Technology Sector Comparison

Comparing ORCL against 149 companies in the Technology sector (10 bullish, 66 neutral, 73 bearish)
P/E Ratio
35.92
This Stock
vs
90.97
Sector Avg
-60.5% (Discount)
Return on Equity (ROE)
69.03%
This Stock
vs
-8.13%
Sector Avg
-949.0% (Below Avg)
Profit Margin
25.28%
This Stock
vs
-7.75%
Sector Avg
-426.0% (Weaker)
Debt to Equity
4.33
This Stock
vs
0.76
Sector Avg
+465.9% (Higher)
Revenue Growth
14.2%
This Stock
vs
56.87%
Sector Avg
-75.0% (Slower)
Current Ratio
0.91
This Stock
vs
3.33
Sector Avg
-72.7% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
ORCL
Oracle Corporation
NEUTRAL $549.03B 35.92 69.0% 25.3% $191.09
ASML
ASML Holding N.V.
NEUTRAL $569.58B 49.74 50.5% 29.4% $1450.56
PLTR
Palantir Technologies Inc.
NEUTRAL $410.28B 1740.1 19.5% 28.1% $174.01
MU
Micron Technology, Inc.
NEUTRAL $408.28B 34.42 22.6% 28.1% $362.75
AMD
Advanced Micro Devices, Inc.
NEUTRAL $315.31B 74.1 7.1% 12.5% $193.39

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2025-12-24 HURA MARK Officer Sale 15,000 $2,953,314
2025-12-23 SELIGMAN NAOMI O Director Sale 2,223 $437,064
2025-12-22 HURA MARK Officer Gift 5,000 -
2025-12-19 MAGOUYRK CLAYTON M Chief Executive Officer Sale 10,000 $1,925,152
2025-12-05 SMITH MARIA Officer Stock Award 11,016 -
2025-10-28 BERG JEFFREY S Director Sale 49,365 $13,971,267
2025-10-23 SMITH MARIA Officer Sale 10,000 $2,803,122
2025-10-21 MAGOUYRK CLAYTON M Chief Executive Officer Sale 40,000 $11,065,508
2025-10-10 LEVEY STUART A Officer Sale 19,758 $5,927,400
2025-09-26 SELIGMAN NAOMI O Director Gift 1,406 -
2025-09-26 SELIGMAN NAOMI O Director Sale 2,222 $641,958
2025-09-23 SICILIA MICHAEL D Officer Sale 33,845 $10,869,660
2025-09-19 SMITH MARIA Officer Stock Award 17,440 -
2025-09-19 SICILIA MICHAEL D Officer Stock Award 109,212 -
2025-09-19 MAGOUYRK CLAYTON M Officer Stock Award 129,861 -
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
38 analysts
UBS
2026-01-05
Maintains
Buy Buy
RBC Capital
2026-01-05
Maintains
Sector Perform Sector Perform
Jefferies
2026-01-05
Maintains
Buy Buy
Goldman Sachs
2025-12-12
Maintains
Neutral Neutral
UBS
2025-12-11
Maintains
Buy Buy
Citigroup
2025-12-11
Maintains
Buy Buy
DA Davidson
2025-12-11
Maintains
Neutral Neutral
JP Morgan
2025-12-11
Maintains
Neutral Neutral
Scotiabank
2025-12-11
Maintains
Sector Outperform Sector Outperform
TD Cowen
2025-12-11
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning ORCL from our newsroom.

Newest → oldest
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile